Furthermore, the study found that elevated serum MIC-1 concentrations were associated with significant weight loss that could be reversed by using antibodies to MIC-1, and serum MIC-1 concentrations were significantly associated with weight loss in patients with cachectic prostate cancer. This evidence concerns the gene GDF15 and prostate cancer.